Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Recalls & Warnings November 09, 2010 Misleading Claims by "One a Day Men's" Products Result in $3.3 Million Settlement On October 26, 2010, Attorneys General from California, Illinois and Oregon announced a $3.3 million dollar settlement with Bayer Healthcare over the companys alleged misleading claims that its One A Day Mens multivitamins reduced the risk of prostate cancer
Maveropepimut-S, a DPX-based immune-educating therapy, shows promising and durable clinical benefit in patients with recurrent ovarian cancer, a phase II trial
Second, ALCAR donates its acetyl group to form Acetyl-CoA, which is a direct, rate-limiting precursor for the synthesis of acetylcholine
Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure
Adding glutathione to another IV can be a cost effective option for people who already plan to receive an IV infusion
US$ 28.24
US$ 24.29
US$ 22.65
US$ 25.78
US$ 26.52
US$ 26.87
US$ 21.84
